KARIN MYERS: Open Payments
NPI 1134213853 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 22 payments from 9 companies in 2025. Trend: 2023 $597 · 2024 $388 · 2025 $578
Food & beverage: $479Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $172 |
| ABBVIE INC. | 5 | $105 |
| LEO Pharma Inc. | 3 | $82 |
| GENZYME CORPORATION | 3 | $81 |
| Galderma Laboratories, L.P. | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| PFIZER INC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: TREMFYA, SKYRIZI, ANZUPGO, DUPIXENT, NEMLUVIO, COSENTYX, CIBINQO, Sotyktu.
Industry payments across AZ — which companies pay providers there.
